No abstract available
Keywords:
Otezla; acitretin; adalimumab; apremilast; bimekizumab; cyclosporine; etanercept; feet; guselkumab; hands; imsidolimab; infliximab; ixekizumab; methotrexate; network meta-analysis; palmoplantar; palms; psoriasis; pustulosis; secukinumab; soles; spesolimab; tofacitinib; upadacitinib; ustekinumab.
Publication types
-
Meta-Analysis
-
Systematic Review
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adalimumab / therapeutic use
-
Administration, Oral
-
Biological Products* / therapeutic use
-
Dermatologic Agents* / therapeutic use
-
Etanercept / therapeutic use
-
Humans
-
Network Meta-Analysis
-
Psoriasis* / complications
-
Psoriasis* / drug therapy
-
Randomized Controlled Trials as Topic
-
Severity of Illness Index
-
Treatment Outcome
-
Ustekinumab / therapeutic use
Substances
-
Biological Products
-
Ustekinumab
-
Adalimumab
-
Etanercept
-
Dermatologic Agents